KCT0008039
Active, not recruiting
未知
Clinical trial to evaluate the safety and efficacy for improvement of gastrocnemius hypertrophy of botulax® injection.
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Asan Medical Center
- Enrollment
- 20
- Status
- Active, not recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) A person between the ages of 20 and 60 who want contour correction of the gastrocnemius muscle
- •2\) A person who can follow the clinical trial procedure well and abide by the visit schedule
- •3\) Those who voluntarily signed the consent form
Exclusion Criteria
- •1\) Patients with diseases that can affect neuromuscular function, such as myasthenia gravis, Eaton\-Lamberton syndrome, amyotrophic lateral sclerosis, and motor neuropathy
- •2\) Aminoglycoside antibiotics, curare\-like agents, or drugs that inhibit neuromuscular function (muscle relaxants such as tubocurarine, dancrolen sodium, and baclofen, anticholinergics, and benzodiazepines) antibiotics, benzamide, tetracycline, lincomycin antibiotics, etc.)
- •3\) Patients with a history of recent alcoholism or drug misuse
- •4\) Patients with skin abnormalities such as infections, skin diseases, or scars at the injection site
- •5\) If you have had other procedures that may affect gastrocnemius treatment within 6 months prior to baseline
- •6\) Those who have received botulinum toxin preparations within 6 months before baseline
- •7\) Patients with a history of facial nerve palsy or ptosis
- •8\) Those taking aspirin, NSAIDs or anticoagulants
- •9\) A woman who is pregnant, lactating, or of childbearing potential who does not agree to contraception by a medically accepted method for up to 8 weeks after drug administration
- •10\) A person who has rapidly lost weight
Outcomes
Primary Outcomes
Not specified
Similar Trials
Terminated
Not Applicable
Clinical trial to evaluate the safety and efficacy of synthetic bone graft substitutes with growth factors for posterior lumbar interbody fusioKCT0004738The Catholic University of Korea, Seoul St. Mary's Hospital20
Completed
Phase 1
Clinical trial of ShatPlus in SARS-CoV-2 Infection.Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereCTRI/2020/05/025340BVG Life Sciences Ltd BVG Group60
Completed
Not Applicable
Clinical trial to evaluate the safety and efficacy of cinnamon extracts on the improvement of bowel function and microfloraDiseases of the digestive systemKCT0003399Semyung University Oriental Medicine Hospital70
Completed
Not Applicable
Clinical trial to evaluate the safety and efficacy for improvement trapezius hypertrophy of botulax® injection.Factors influencing health status and contact with health servicesKCT0009443Asan Medical Center20
Not yet recruiting
Not Applicable
Clinical trial to evaluate the efficacy and safety of massage using a CMP-100 medical device in patients with shoulder-back myofascial pain syndromKCT0003971Wonkwang University, Gwangju Medical Center40